Piscitelli Dominic — SEC insider filings
SEC reporting owner CIK 1695028. 24 insider filings on record with FilingPulse; latest filed 2026-10-21.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2021-02-02 to 2026-10-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 60,000 shares, $321,624 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 22 legs across 16 filings — 257,169 shares, $3,141,771 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 77,000 shares @ $13.69 ($1,053,814) in Oric Pharmaceuticals, Inc., filed 2026-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | Chief Financial Officer | 24 | 1 leg · 60,000 sh · $321,624 | 22 legs · 257,169 sh · $3,141,771 | 46 |
Insider filings — Piscitelli Dominic
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-21 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 14,000 @ $4.36 · Sale (S): 14,000 @ $13.53 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2026-09-29 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 13,400 @ $4.36 · Sale (S): 13,400 @ $13.53 · Option exercise (M): 13,400 (derivative) @ $0 | EDGAR |
| 2026-09-25 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 600 @ $4.36 · Sale (S): 100 @ $13.50 · Sale (S): 500 @ $13.51 · Option exercise (M): 600 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 52,000 @ $4.36 · Option exercise (M): 25,000 @ $6 · Sale (S): 77,000 @ $13.69 · Option exercise (M): 52,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 52,000 @ $4.36 · Sale (S): 52,000 @ $13.51 · Option exercise (M): 52,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 206,500 (derivative) @ $0 · Grant/award (A): 34,500 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 29,333 @ $0 · Sale (S): 10,720 @ $9.06 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 11,333 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 11,000 @ $4.36 · Sale (S): 11,000 @ $14.52 · Option exercise (M): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 20,000 @ $10.05 | EDGAR |
| 2025-06-24 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 584 @ $10 · Sale (S): 450 @ $10.01 · Sale (S): 32,466 @ $10.50 | EDGAR |
| 2025-06-13 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 300 @ $10 | EDGAR |
| 2025-06-11 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 324 @ $10 · Sale (S): 1,276 @ $10 · Sale (S): 1,700 @ $10.01 | EDGAR |
| 2025-06-09 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 2,600 @ $10.01 · Sale (S): 300 @ $10 | EDGAR |
| 2025-01-03 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 202,500 (derivative) @ $0 · Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 24,042 @ $0 · Sale (S): 8,851 @ $8.28 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 180,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 14,042 @ $0 · Sale (S): 5,282 @ $8.58 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4/A | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 2,227 @ $3.08 | EDGAR |
| 2023-02-02 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 145,000 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 6,041 @ $0 · Sale (S): 2,089 @ $3.25 · Option exercise (M): 6,041 (derivative) @ $0 | EDGAR |
| 2022-07-21 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Disposition to issuer (D): 207,500 (derivative) · Disposition to issuer (D): 86,250 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 108,750 (derivative) · Grant/award (A): 207,500 (derivative) · Grant/award (A): 86,250 (derivative) · +2 more | EDGAR |
| 2022-03-31 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Purchase (P): 60,000 @ $5.36 | EDGAR |
| 2022-02-02 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 108,750 (derivative) @ $0 · Grant/award (A): 18,125 (derivative) @ $0 | EDGAR |
| 2021-02-02 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1695028 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs